X Chromosomal Variation Is Associated with Slow Progression to AIDS in HIV-1-Infected Women

American Journal of Human Genetics

Volumn 85, Issue 2, 2009, Pages 228-239

  Siddiqui, Roman A ^a   Sauermann, Ulrike ^b   Altmüller, Janine ^c   Fritzer, Elfriede ^d   Nothnagel, Michael ^d   Dalibor, Nina ^c   Fellay, Jacques ^e   Kaup, Franz Josef ^b   Stahl Hennig, Christiane ^b   Nürnberg, Peter ^c,f   Krawczak, Michael ^d   Platzer, Matthias ^a  

^a FRITZ LIPMANN INSTITUTE   (Germany)

^b GERMAN PRIMATE CENTER   (Germany)

^c UNIVERSITY OF COLOGNE   (Germany)

^d UNIVERSITY OF KIEL   (Germany)

^e DUKE UNIVERSITY   (United States)

^f UNIVERSITY OF COLOGNE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CD4 ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MESSENGER RNA; MICROSATELLITE DNA; S6 KINASE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CD4+ T LYMPHOCYTE; CYLICIN 1 GENE; DISEASE COURSE; FEMALE; GENE; GENE FREQUENCY; GENE LINKAGE DISEQUILIBRIUM; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE MAP; HETEROZYGOTE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MAJOR CLINICAL STUDY; MALE; MICROSATELLITE MARKER; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; RACE DIFFERENCE; RHESUS MONKEY; RIBOSOMAL PROTEIN S6 KINASE 6 GENE; SCORING SYSTEM; SEX DIFFERENCE; SIMIAN IMMUNODEFICIENCY VIRUS; SINGLE NUCLEOTIDE POLYMORPHISM; VIRUS LOAD; X CHROMOSOME;

ACQUIRED IMMUNODEFICIENCY SYNDROME; ALLELES; CHROMOSOMES, HUMAN, X; DISEASE PROGRESSION; FEMALE; GENE FREQUENCY; GENETIC VARIATION; HETEROZYGOTE; HIV INFECTIONS; HIV-1; HUMANS; MALE; PHENOTYPE; POLYMORPHISM, SINGLE NUCLEOTIDE; SEX FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS 1; MACACA MULATTA; SIMIAN IMMUNODEFICIENCY VIRUS;

EID: 68249129930     PISSN: 00029297     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ajhg.2009.07.013     Document Type: Article

References (63)

1. O'Brien S.J., and Nelson G.W. Human genes that limit AIDS. Nat. Genet. 36 (2004) 565-574
2. Fellay J., Shianna K.V., Ge D., Colombo S., Ledergerber B., Weale M., Zhang K., Gumbs C., Castagna A., Cossarizza A., et al. A whole-genome association study of major determinants for host control of HIV-1. Science 317 (2007) 944-947
3. Limou S., Le Clerc S., Coulonges C., Carpentier W., Dina C., Delaneau O., Labib T., Taing L., Sladek R., Deveau C., et al. Genomewide association study of an AIDS-nonprogression cohort emphasizes the role played by HLA genes (ANRS Genomewide Association Study 02). J. Infect. Dis. 199 (2009) 419-426
4. van Manen D., Kootstra N.A., Boeser-Nunnink B., Handulle M.A., van't Wout A.B., and Schuitemaker H. Association of HLA-C and HCP5 gene regions with the clinical course of HIV-1 infection. AIDS 23 (2009) 19-28
5. *57 alleles. PLoS ONE 3 (2008) e3636
6. Brass A.L., Dykxhoorn D.M., Benita Y., Yan N., Engelman A., Xavier R.J., Lieberman J., and Elledge S.J. Identification of host proteins required for HIV infection through a functional genomic screen. Science 319 (2008) 921-926
7. Konig R., Zhou Y., Elleder D., Diamond T.L., Bonamy G.M., Irelan J.T., Chiang C.Y., Tu B.P., De Jesus P.D., Lilley C.E., et al. Global analysis of host-pathogen interactions that regulate early-stage HIV-1 replication. Cell 135 (2008) 49-60
8. Zhou H., Xu M., Huang Q., Gates A.T., Zhang X.D., Castle J.C., Stec E., Ferrer M., Strulovici B., Hazuda D.J., et al. Genome-scale RNAi screen for host factors required for HIV replication. Cell Host Microbe 4 (2008) 495-504
9. Ahmed R.K., Biberfeld G., and Thorstensson R. Innate immunity in experimental SIV infection and vaccination. Mol. Immunol. 42 (2005) 251-258
10. Morgan C., Marthas M., Miller C., Duerr A., Cheng-Mayer C., Desrosiers R., Flores J., Haigwood N., Hu S.L., Johnson R.P., et al. The use of nonhuman primate models in HIV vaccine development. PLoS Med. 5 (2008) e173
11. Watkins D.I., Burton D.R., Kallas E.G., Moore J.P., and Koff W.C. Nonhuman primate models and the failure of the Merck HIV-1 vaccine in humans. Nat. Med. 14 (2008) 617-621
12. Muhl T., Krawczak M., Ten Haaft P., Hunsmann G., and Sauermann U. MHC class I alleles influence set-point viral load and survival time in simian immunodeficiency virus-infected rhesus monkeys. J. Immunol. 169 (2002) 3438-3446
13. Sauermann U., Siddiqui R., Suh Y.S., Platzer M., Leuchte N., Meyer H., Matz-Rensing K., Stoiber H., Nurnberg P., Hunsmann G., et al. Mhc class I haplotypes associated with survival time in simian immunodeficiency virus (SIV)-infected rhesus macaques. Genes Immun. 9 (2008) 69-80
14. Hirsch V.M., Santra S., Goldstein S., Plishka R., Buckler-White A., Seth A., Ourmanov I., Brown C.R., Engle R., Montefiori D., et al. Immune failure in the absence of profound CD4+ T-lymphocyte depletion in simian immunodeficiency virus-infected rapid progressor macaques. J. Virol. 78 (2004) 275-284
15. Sauermann U., Stahl-Hennig C., Stolte N., Muhl T., Krawczak M., Spring M., Fuchs D., Kaup F.J., Hunsmann G., and Sopper S. Homozygosity for a conserved Mhc class II DQ-DRB haplotype is associated with rapid disease progression in simian immunodeficiency virus-infected macaques: Results from a prospective study. J. Infect. Dis. 182 (2000) 716-724
16. Rogers J., Garcia R., Shelledy W., Kaplan J., Arya A., Johnson Z., Bergstrom M., Novakowski L., Nair P., Vinson A., et al. An initial genetic linkage map of the rhesus macaque (Macaca mulatta) genome using human microsatellite loci. Genomics 87 (2006) 30-38
17. Holm S. A simple sequentially rejective multiple test procedure. Scandinavian Journal of Statistics 6 (1979) 65-70
18. Weir B.S., and Cockerham C.C. Estimating F-statistics for the analysis of population structure. Evolution 38 (1984) 1358-1370
19. Wigginton J.E., Cutler D.J., and Abecasis G.R. A note on exact tests of Hardy-Weinberg equilibrium. Am. J. Hum. Genet. 76 (2005) 887-893
20. R Development Core Team. R: A language and environment for statistical computing (2008), R Foundation for Statistical Computing, Vienna, Austria
21. Price A.L., Patterson N.J., Plenge R.M., Weinblatt M.E., Shadick N.A., and Reich D. Principal components analysis corrects for stratification in genome-wide association studies. Nat. Genet. 38 (2006) 904-909
22. Lao O., Lu T.T., Nothnagel M., Junge O., Freitag-Wolf S., Caliebe A., Balascakova M., Bertranpetit J., Bindoff L.A., Comas D., et al. Correlation between genetic and geographic structure in Europe. Curr. Biol. 18 (2008) 1241-1248
23. Barrett J.C., Fry B., Maller J., and Daly M.J. Haploview: Analysis and visualization of LD and haplotype maps. Bioinformatics 21 (2005) 263-265
24. Carlson C.S., Eberle M.A., Rieder M.J., Yi Q., Kruglyak L., and Nickerson D.A. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am. J. Hum. Genet. 74 (2004) 106-120
25. Frazer K.A., Ballinger D.G., Cox D.R., Hinds D.A., Stuve L.L., Gibbs R.A., Belmont J.W., Boudreau A., Hardenbol P., Leal S.M., et al. A second generation human haplotype map of over 3.1 million SNPs. Nature 449 (2007) 851-861
26. Szafranski K., Jahn N., and Platzer M. tuple_plot: Fast pairwise nucleotide sequence comparison with noise suppression. Bioinformatics 22 (2006) 1917-1918
27. Martin M.P., and Carrington M. Immunogenetics of viral infections. Curr. Opin. Immunol. 17 (2005) 510-516
28. O'Connor D.H., Mothe B.R., Weinfurter J.T., Fuenger S., Rehrauer W.M., Jing P., Rudersdorf R.R., Liebl M.E., Krebs K., Vasquez J., et al. Major histocompatibility complex class I alleles associated with slow simian immunodeficiency virus disease progression bind epitopes recognized by dominant acute-phase cytotoxic-T-lymphocyte responses. J. Virol. 77 (2003) 9029-9040
29. Korenromp E.L., Williams B.G., Schmid G.P., and Dye C. Clinical prognostic value of RNA viral load and CD4 cell counts during untreated HIV-1 infection - a quantitative review. PLoS ONE 4 (2009) e5950
30. Stranger B.E., Nica A.C., Forrest M.S., Dimas A., Bird C.P., Beazley C., Ingle C.E., Dunning M., Flicek P., Koller D., et al. Population genomics of human gene expression. Nat. Genet. 39 (2007) 1217-1224
31. Pal R., Venzon D., Letvin N.L., Santra S., Montefiori D.C., Miller N.R., Tryniszewska E., Lewis M.G., VanCott T.C., Hirsch V., et al. ALVAC-SIV-gag-pol-env-based vaccination and macaque major histocompatibility complex class I (A*01) delay simian immunodeficiency virus SIVmac-induced immunodeficiency. J. Virol. 76 (2002) 292-302
32. Fish E.N. The X-files in immunity: Sex-based differences predispose immune responses. Nat. Rev. Immunol. 8 (2008) 737-744
33. Ober C., Loisel D.A., and Gilad Y. Sex-specific genetic architecture of human disease. Nat. Rev. Genet. 9 (2008) 911-922
34. Carriere A., Ray H., Blenis J., and Roux P.P. The RSK factors of activating the Ras/MAPK signaling cascade. Front. Biosci. 13 (2008) 4258-4275
35. Xing J., Ginty D.D., and Greenberg M.E. Coupling of the RAS-MAPK pathway to gene activation by RSK2, a growth factor-regulated CREB kinase. Science 273 (1996) 959-963
36. Dummler B.A., Hauge C., Silber J., Yntema H.G., Kruse L.S., Kofoed B., Hemmings B.A., Alessi D.R., and Frodin M. Functional characterization of human RSK4, a new 90-kDa ribosomal S6 kinase, reveals constitutive activation in most cell types. J. Biol. Chem. 280 (2005) 13304-13314
37. Thakur A., Sun Y., Bollig A., Wu J., Biliran H., Banerjee S., Sarkar F.H., and Liao D.J. Anti-invasive and antimetastatic activities of ribosomal protein S6 kinase 4 in breast cancer cells. Clin. Cancer Res. 14 (2008) 4427-4436
38. Jiang G., Espeseth A., Hazuda D.J., and Margolis D.M. c-Myc and Sp1 contribute to proviral latency by recruiting histone deacetylase 1 to the human immunodeficiency virus type 1 promoter. J. Virol. 81 (2007) 10914-10923
39. Connor R.I., Sheridan K.E., Ceradini D., Choe S., and Landau N.R. Change in coreceptor use correlates with disease progression in HIV-1-infected individuals. J. Exp. Med. 185 (1997) 621-628
40. Evans M.J., von Hahn T., Tscherne D.M., Syder A.J., Panis M., Wolk B., Hatziioannou T., McKeating J.A., Bieniasz P.D., and Rice C.M. Claudin-1 is a hepatitis C virus co-receptor required for a late step in entry. Nature 446 (2007) 801-805
41. Lu T.S., Avraham H.K., Seng S., Tachado S.D., Koziel H., Makriyannis A., and Avraham S. Cannabinoids inhibit HIV-1 Gp120-mediated insults in brain microvascular endothelial cells. J. Immunol. 181 (2008) 6406-6416
42. Verma S., Lo Y., Chapagain M., Lum S., Kumar M., Gurjav U., Luo H., Nakatsuka A., and Nerurkar V.R. West Nile virus infection modulates human brain microvascular endothelial cells tight junction proteins and cell adhesion molecules: Transmigration across the in vitro blood-brain barrier. Virology 385 (2009) 425-433
43. Zheng J., Xie Y., Campbell R., Song J., Massachi S., Razi M., Chiu R., Berenson J., Yang O.O., Chen I.S., et al. Involvement of claudin-7 in HIV infection of CD4(-) cells. Retrovirology 2 (2005) 79
44. Su A.I., Wiltshire T., Batalov S., Lapp H., Ching K.A., Block D., Zhang J., Soden R., Hayakawa M., Kreiman G., et al. A gene atlas of the mouse and human protein-encoding transcriptomes. Proc. Natl. Acad. Sci. USA 101 (2004) 6062-6067
45. Squires K.E. Treating HIV infection and AIDS in women. AIDS Read 13 (2003) 228-234, 239-240
46. Squires K.E. Gender differences in the diagnosis and treatment of HIV. Gend. Med. 4 (2007) 294-307
47. Madkan V.K., Giancola A.A., Sra K.K., and Tyring S.K. Sex differences in the transmission, prevention, and disease manifestations of sexually transmitted diseases. Arch. Dermatol. 142 (2006) 365-370
48. Quinn T.C., and Overbaugh J. HIV/AIDS in women: An expanding epidemic. Science 308 (2005) 1582-1583
49. Mofenson L.M., Harris D.R., Rich K., Meyer III W.A., Read J.S., Moye Jr. J., Nugent R.P., Korelitz J., Bethel J., and Pahwa S. Serum HIV-1 p24 antibody, HIV-1 RNA copy number and CD4 lymphocyte percentage are independently associated with risk of mortality in HIV-1-infected children. National Institute of Child Health and Human Development Intravenous Immunoglobulin Clinical Trial Study Group. AIDS 13 (1999) 31-39
50. Collazos J., Asensi V., and Carton J.A. Sex differences in the clinical, immunological and virological parameters of HIV-infected patients treated with HAART. AIDS 21 (2007) 835-843
51. Jarrin I., Geskus R., Bhaskaran K., Prins M., Perez-Hoyos S., Muga R., Hernandez-Aguado I., Meyer L., Porter K., and del Amo J. Gender differences in HIV progression to AIDS and death in industrialized countries: Slower disease progression following HIV seroconversion in women. Am. J. Epidemiol. 168 (2008) 532-540
52. Nicastri E., Angeletti C., Palmisano L., Sarmati L., Chiesi A., Geraci A., Andreoni M., and Vella S. Gender differences in clinical progression of HIV-1-infected individuals during long-term highly active antiretroviral therapy. AIDS 19 (2005) 577-583
53. Nicastri E., Leone S., Angeletti C., Palmisano L., Sarmati L., Chiesi A., Geraci A., Vella S., Narciso P., Corpolongo A., et al. Sex issues in HIV-1-infected persons during highly active antiretroviral therapy: A systematic review. J. Antimicrob. Chemother. 60 (2007) 724-732
54. Napravnik S., Poole C., Thomas J.C., and Eron Jr. J.J. Gender difference in HIV RNA levels: A meta-analysis of published studies. J. Acquir. Immune Defic. Syndr. 31 (2002) 11-19
55. Sterling T.R., Vlahov D., Astemborski J., Hoover D.R., Margolick J.B., and Quinn T.C. Initial plasma HIV-1 RNA levels and progression to AIDS in women and men. N. Engl. J. Med. 344 (2001) 720-725
56. Foca M., Moye J., Chu C., Matthews Y., Rich K., Handelsman E., Luzuriaga K., Paul M., and Diaz C. Gender differences in lymphocyte populations, plasma HIV RNA levels, and disease progression in a cohort of children born to women infected with HIV. Pediatrics 118 (2006) 146-155
57. Amadori A., Zamarchi R., De Silvestro G., Forza G., Cavatton G., Danieli G.A., Clementi M., and Chieco-Bianchi L. Genetic control of the CD4/CD8 T-cell ratio in humans. Nat. Med. 1 (1995) 1279-1283
58. Lyon M.F. Evolution of X-chromosome inactivation in mammals. Nature 250 (1974) 651-653
59. Carrel L., and Willard H.F. X-inactivation profile reveals extensive variability in X-linked gene expression in females. Nature 434 (2005) 400-404
60. Knudsen G.P., Pedersen J., Klingenberg O., Lygren I., and Orstavik K.H. Increased skewing of X chromosome inactivation with age in both blood and buccal cells. Cytogenet. Genome Res. 116 (2007) 24-28
61. Ge D., Zhang K., Need A.C., Martin O., Fellay J., Urban T.J., Telenti A., and Goldstein D.B. WGAViewer: Software for genomic annotation of whole genome association studies. Genome Res. 18 (2008) 640-643
62. Blanchette M., Kent W.J., Riemer C., Elnitski L., Smit A.F., Roskin K.M., Baertsch R., Rosenbloom K., Clawson H., Green E.D., et al. Aligning multiple genomic sequences with the threaded blockset aligner. Genome Res. 14 (2004) 708-715
63. Siepel A., Bejerano G., Pedersen J.S., Hinrichs A.S., Hou M., Rosenbloom K., Clawson H., Spieth J., Hillier L.W., Richards S., et al. Evolutionarily conserved elements in vertebrate, insect, worm, and yeast genomes. Genome Res. 15 (2005) 1034-1050